IRIS
MORSIA, Erika
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.525
AS - Asia 1.320
EU - Europa 1.094
SA - Sud America 376
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 105
OC - Oceania 3
Totale 5.584
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.398
IT - Italia 417
SG - Singapore 354
VN - Vietnam 334
BR - Brasile 282
CN - Cina 250
RU - Federazione Russa 221
HK - Hong Kong 135
FR - Francia 87
DE - Germania 80
BD - Bangladesh 66
IE - Irlanda 52
CA - Canada 48
IN - India 48
CI - Costa d'Avorio 46
GB - Regno Unito 46
NL - Olanda 39
AR - Argentina 38
FI - Finlandia 38
MX - Messico 34
SE - Svezia 21
AT - Austria 20
ID - Indonesia 17
MA - Marocco 17
JP - Giappone 16
LT - Lituania 16
PL - Polonia 16
ES - Italia 15
EC - Ecuador 14
VE - Venezuela 13
IQ - Iraq 12
ZA - Sudafrica 12
CR - Costa Rica 11
TR - Turchia 11
CO - Colombia 9
PE - Perù 8
TH - Thailandia 8
UZ - Uzbekistan 8
HN - Honduras 7
AE - Emirati Arabi Uniti 6
PH - Filippine 6
PK - Pakistan 6
PY - Paraguay 6
CL - Cile 5
CW - ???statistics.table.value.countryCode.CW??? 5
IL - Israele 5
KR - Corea 5
SN - Senegal 5
TN - Tunisia 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
EG - Egitto 4
GT - Guatemala 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
MY - Malesia 4
NP - Nepal 4
SV - El Salvador 4
BS - Bahamas 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AL - Albania 2
AU - Australia 2
BW - Botswana 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
KE - Kenya 2
MT - Malta 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
TZ - Tanzania 2
UA - Ucraina 2
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CH - Svizzera 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 5.423
Salva come PNG Salva come JPEG
Città #
Ashburn 626
Singapore 216
Dallas 198
Council Bluffs 182
San Jose 173
Hong Kong 129
Ho Chi Minh City 116
Los Angeles 100
Boardman 91
Hanoi 79
Beijing 58
Dublin 51
Hefei 50
New York 50
Abidjan 46
Lauterbourg 45
Ancona 42
Munich 40
Milan 39
Chandler 38
Buffalo 37
Chicago 37
Moscow 34
The Dalles 32
São Paulo 30
Rome 29
Santa Clara 29
Phoenix 28
Helsinki 25
Denver 24
Orem 22
Turin 20
Brooklyn 18
Salt Lake City 17
Washington 17
Montreal 16
Chennai 15
Frankfurt am Main 15
Haiphong 15
Mexico City 15
Nuremberg 15
Amsterdam 13
Turku 13
San Francisco 12
Vilnius 12
Atlanta 11
Bari 11
Da Nang 11
London 11
Naples 11
Seattle 11
Tokyo 11
Warsaw 11
Guangzhou 10
Houston 9
Stockholm 9
Boston 8
San José 8
Shanghai 8
Tashkent 8
Elk Grove Village 7
Manchester 7
Miami 7
Mumbai 7
Palermo 7
Rio de Janeiro 7
Toronto 7
Belton 6
Caracas 6
Hải Dương 6
Irvington 6
Johannesburg 6
Ninh Bình 6
Tampa 6
Vienna 6
Baghdad 5
Bangkok 5
Bologna 5
Can Tho 5
Columbus 5
Dakar 5
Falconara Marittima 5
Florence 5
Lima 5
Medellín 5
New Delhi 5
North Charleston 5
Osimo 5
Paris 5
Princeton 5
Willemstad 5
Wuhan 5
Andria 4
Baku 4
Biên Hòa 4
Brasília 4
Campinas 4
Cardiff 4
Charlotte 4
City of London 4
Totale 3.271
Salva come PNG Salva come JPEG
Nome #
Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region 177
Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations 165
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 165
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 161
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas 151
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 145
A rare case of aCML associated with CNS involvement and with aggressive clinical course 145
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications 142
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 136
NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES 135
Bone Marrow Adipose Tissue 134
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 131
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 127
Clinico-Pathological, Cytogenetic and Molecular Similarities and Differences between Primary and Secondary Cutaneous Lymphomas 124
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 124
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 123
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients 120
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 119
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 115
AL amyloidosis: an overview on diagnosis, staging system, and treatment 115
Myeloproliferative Neoplasms with Monocytosis 114
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 114
Transfusion dependence is a risk factor for severe infections in myelodysplastic syndromes 112
Pediatric primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: A retrospective analysis and review of the literature 111
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 111
Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project 110
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights 109
Is There a Correlation Between Immune Thrombocytopenia and Immunoglobulin G4-Related Disease? 105
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 102
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI) 95
P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS? 94
Expression of Paraoxonase-2 in Different Stages of Cutaneous T Cell Lymphoma: Is It a Potential Biomarker for Aggressiveness? 94
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy 92
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management 91
Epidemiology and Risk Factors for Infections in Myelodysplastic Syndromes 86
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study 84
Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiences 80
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients 80
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea 77
Myelofibrosis: challenges for preclinical models and emerging therapeutic targets 77
Sequential Bispecific Antibodies in Functional and Clinical High Risk Multiple Myeloma, Manifesting with Extramedullary Disease at Relapse: A Case Report 77
Erythroid-stimulating agents in VEXAS syndrome: A retrospective study from an Italian multicentre cohort 74
Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma 73
Mutations and thrombosis in essential thrombocythemia 73
IDH2 Inhibitor Therapy in Relapsed and Refractory Acute Myeloid Leukemia: A Single Institution Experience 72
Disease Phenotype Significantly Influences the Outcome After Discontinuation of Ruxolitinib in Chronic Phase Myelofibrosis 72
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome 72
WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic 69
Paraoxonase-2 in cutaneous T cell lymphomas. 68
Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients 65
Ruxolitinib after fedratinib failure in patients with myelofibrosis: A real-world case series 63
Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter study 58
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice? 32
Genetic insights into myeloproliferative neoplasms and unusual sites thrombosis 24
Totale 5.584
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.725
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202222 0 0 0 0 0 1 3 2 0 3 6 7
2022/2023157 6 9 7 12 7 9 1 9 26 0 60 11
2023/2024378 37 12 38 44 57 54 11 13 3 28 15 66
2024/20251.011 66 66 38 19 31 53 96 24 171 55 193 199
2025/20263.250 213 252 295 384 311 253 525 260 246 260 128 123
2026/2027758 156 92 103 404 3 0 0 0 0 0 0 0
Totale 5.584